SIGA Technologies Inc (SIGA)

SIGA Technologies Inc (SIGA) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $234M; returns 1 day -1.0%, 1 week -1.6%, 1 year -62.9%.

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on health security and biodefense. Its business model is almost entirely dependent on the sale of its sole commercial product, TPOXX (tecovirimat), an antiviral drug approved for the treatment of human smallpox disease caused by the variola virus, and effective against other orthopoxviruses like mpox.

Groups SIGA belongs to

• Pharmaceuticals
• Commercial Stage
• Commercial Stage Biotech
• Antivirals
• National Security
• Government Contractor
• Public Sector
• Defense Industry
• Healthcare
• Biotechnology

SIGA financial model: income statement, cash flow and balance sheet